Assessing the Utility of Plasma ctHPVDNA for Anal Cancer Screening

Completed

Conditions studied: Anal Dysplasia

In brief

The study is to test a liquid biopsy assay for screening and classifying anal dysplasia from blood.

Key facts

Study ID

NCT06971276

Run by

Massachusetts Eye and Ear Infirmary

People needed

104

Starts

2024-04-03

Expected to finish

2025-12-31

Last updated by the study team

2026-04-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Past or current anal HPV-positive population undergone anal dysplasia screening.
• Control patients from the general population.

You may not qualify if…

• Not meeting inclusion criteria.

Where it is running

• Department of Infectious Diseases, Mass General Hospital — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.